Iressa & Malignant neoplasm progression

28.8%

of users reported Malignant neoplasm progression

89.6%

also reported Severe reaction

69.4%

are women

Severe reaction

89.6%

Death

7.6%

Hospitalization

2.4%

Life-threatening condition

0.3%

Iressa: general information

40 - 49 years

2.3%

50 - 59 years

18.1%

60 - 69 years

31.6%

70 - 79 years

28.3%

80 - 89 years

18.9%

90 - 99 years

0.8%